{
    "ticker": "EXAS",
    "name": "Exact Sciences Corporation",
    "description": "Exact Sciences Corporation is a leading molecular diagnostics company focused on the early detection and prevention of cancer. Founded in 1995 and headquartered in Madison, Wisconsin, Exact Sciences develops innovative screening tests, including Cologuard, which is the first and only FDA-approved non-invasive stool DNA test for colorectal cancer screening. The company's mission is to provide patients and healthcare providers with accurate and accessible cancer screening options to improve health outcomes. Exact Sciences also offers a suite of other cancer diagnostic tests, leveraging advanced technologies such as next-generation sequencing and bioinformatics. The company prioritizes research and development to continuously enhance its testing capabilities and expand its product offerings in the oncology space. Exact Sciences is committed to making a meaningful impact on public health by increasing awareness and improving access to cancer screening, ultimately striving to save lives through early detection.",
    "industry": [
        "Healthcare",
        "Diagnostics"
    ],
    "headquarters": "Madison, Wisconsin, USA",
    "founded": "1995",
    "website": "https://www.exactsciences.com",
    "ceo": "Kevin Conroy",
    "social_media": {
        "twitter": "https://twitter.com/ExactSciences",
        "linkedin": "https://www.linkedin.com/company/exact-sciences/"
    },
    "investor_relations": "https://investors.exactsciences.com",
    "key_executives": [
        {
            "name": "Kevin Conroy",
            "position": "CEO"
        },
        {
            "name": "Diana D. H. McKenzie",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cancer Screening Tests",
            "products": [
                "Cologuard",
                "Oncotype DX"
            ]
        }
    ],
    "seo": {
        "meta_title": "Exact Sciences Corporation | Leading Cancer Screening Solutions",
        "meta_description": "Learn about Exact Sciences Corporation, a leader in molecular diagnostics focused on cancer detection and prevention. Discover innovative tests like Cologuard.",
        "keywords": [
            "Exact Sciences",
            "Cancer Screening",
            "Cologuard",
            "Molecular Diagnostics",
            "Oncology"
        ]
    },
    "faq": [
        {
            "question": "What is Exact Sciences known for?",
            "answer": "Exact Sciences is known for its innovative cancer screening tests, particularly Cologuard for colorectal cancer."
        },
        {
            "question": "Who is the CEO of Exact Sciences?",
            "answer": "Kevin Conroy is the CEO of Exact Sciences Corporation."
        },
        {
            "question": "Where is Exact Sciences headquartered?",
            "answer": "Exact Sciences is headquartered in Madison, Wisconsin, USA."
        },
        {
            "question": "What are Exact Sciences' main products?",
            "answer": "Exact Sciences' main products include Cologuard and Oncotype DX."
        },
        {
            "question": "When was Exact Sciences founded?",
            "answer": "Exact Sciences was founded in 1995."
        }
    ],
    "competitors": [
        "GHDX",
        "NTRA"
    ],
    "related_stocks": [
        "AMGN",
        "REGN",
        "BMY",
        "ABBV"
    ]
}